Analysis: How COVID-19 Vaccination Rates Vary Across Different Communities

October 20, 2021Garrett SchmittNo CommentsBiden administration, BioNTech, CMS, community health, Coronavirus, COVID, COVID-19, COVID-19 pandemic, COVID-19 vaccine, EUA, FDA, Janssen, Johnson & Johnson, Medicare, Moderna, Pfizer, Pfizer-BioNTech

The year of 2020 was dominated by the news of how COVID-19 spread around the world, and how life has been changed by the disruption of this pandemic. We have witnessed the journeys of battling the disease, dedication and sacrifices by the front-line heroes, and the emotional roller coaster of wondering when this pandemic would…

Recent Posts

  • HIMSS26: Embedding clinical intelligence for a successful Medicare Shared Savings Program
  • Value-based care practices shift the ‘center of gravity’ of healthcare to prevention and early recognition of disease, says Jaewon Ryu, M.D., J.D., CEO of Risant Health
  • Will The New CMS ACO Model LEAD To Better Care For High-Need Medicare Beneficiaries?
  • Value-Based Care Emerges as a Strategic Anchor in an Uncertain Regulatory Climate
  • Around the nation: Optum launches new AI tool for value-based care
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us